Syngoi Technologies, a leading Contract Development and Manufacturing Organization -CDMO- specializing in synthetic DNA for advanced cell and gene therapies, announces a significant expansion in its production capabilities, enabling the production of DNA at kilograms scale and accommodating more than 25 concurrent customer projects. This expansion follows a successful Series B capital raise – led…
